Study protocol for a randomized controlled trial comparing the efficacy of a specialist and a generic parenting programme for the treatment of preschool ADHD

Trials

Edmund Sonuga-Barke³  James Raftery⁴  Maria Chorozoglou⁴  Josh Caddy⁵  Liz Dixon⁵  Tom Maishman⁵  Louise Stanton⁵  David Coghill¹  Judy Hutchings⁷  Cathy Laver-Bradbury²  Joanne Barton⁸  David Daley⁶  Margaret Thompson²  Donna C McCann³ 

[1] School of Medicine, University of Dundee, Ninewells Hospital, Dundee DD1 9SY, UK;Child and Adolescent Mental Health Services, Solent NHS Trust, Orchard Centre, Southampton SO16 4XE, UK;Developmental Brain and Behaviour Lab, Psychology, University of Southampton, Southampton SO17 1BJ, UK;Wessex Institute for Health, Research and Development, University of Southampton, Southampton Science Park, Southampton SO16 7NS, UK;University of Southampton Clinical Trials Unit, Southampton General Hospital, Southampton SO16 6YD, UK;Division of Psychiatry and Applied Psychology, University of Nottingham, Nottingham NG7 2TU, UK;School of Psychology and Centre for Evidence Based Early Intervention, Bangor University, Bangor LL57 2PX, UK;North Staffordshire Combined Healthcare NHS Trust, Stoke-on-Trent ST1 5UK, UK

关键词: parent training;    parenting programme;    parenting;    effectiveness;    cost-effectiveness;    ADHD;   

Others  :  806710
DOI  :  10.1186/1745-6215-15-142

 received in 2013-10-29, accepted in 2014-04-10,  发布年份 2014

【 摘 要 】

Background

The New Forest Parenting Programme (NFPP) is a home-delivered, evidence-based parenting programme to target symptoms of attention-deficit/hyperactivity disorder (ADHD) in preschool children. It has been adapted for use with ‘hard-to-reach’ or ‘difficult-to-treat’ children. This trial will compare the adapted-NFPP with a generic parenting group-based programme, Incredible Years (IY), which has been recommended for children with preschool-type ADHD symptoms.

Methods/design

This multicentre randomized controlled trial comprises three arms: adapted-NFPP, IY and treatment as usual (TAU). A sample of 329 parents of preschool-aged children with a research diagnosis of ADHD enriched for hard-to-reach and potentially treatment-resistant children will be allocated to the arms in the ratio 3:3:1. Participants in the adapted-NFPP and IY arms receive an induction visit followed by 12 weekly parenting sessions of 1½ hours (adapted-NFPP) or 2½ hours (IY) over 2.5 years. Adapted-NFPP will be delivered as a one-to-one home-based intervention; IY, as a group-based intervention. TAU participants are offered a parenting programme at the end of the study. The primary objective is to test whether the adapted-NFPP produces beneficial effects in terms of core ADHD symptoms. Secondary objectives include examination of the treatment impact on secondary outcomes, a study of cost-effectiveness and examination of the mediating role of treatment-induced changes in parenting behaviour and neuropsychological function. The primary outcome is change in ADHD symptoms, as measured by the parent-completed version of the SNAP-IV questionnaire, adjusted for pretreatment SNAP-IV score. Secondary outcome measures are: a validated index of behaviour during child’s solo play; teacher-reported SNAP-IV (ADHD scale); teacher and parent SNAP-IV (ODD) Scale; Eyberg Child Behaviour Inventory - Oppositional Defiant Disorder scale; Revised Client Service Receipt Inventory - Health Economics Costs measure and EuroQol (EQ5D) health-related quality-of-life measure. Follow-up measures will be collected 6 months after treatment for participants allocated to adapted-NFPP and IY.

Discussion

This trial will provide evidence as to whether the adapted-NFPP is more effective and cost-effective than the recommended treatment and TAU. It will also provide information about mediating factors (improved parenting and neuropsychological function) and moderating factors (parent and child genetic factors) in any increased benefit.

Trial registration

Current Controlled Trials, ISRCTN39288126.

【 授权许可】

   
2014 McCann et al.; licensee BioMed Central Ltd.

【 参考文献 】

• [1]National Institute for Health and Clinical Excellence (NICE): Methylphenidate. Atomoxetine and Dexamfetamine for Attention Deficit Hyperactivity Disorder (ADHD) In Children and Adolescents. Review of Technology Appraisal 13; [http://www.nice.org.uk/nicemedia/live/11572/33222/33222.pdf webcite]
• [2]Swanson JM, Sergeant J, Taylor E, Sonuga-Barke EJS, Jensen PS, Cantwell DP: Attention-deficit hyperactivity disorder and hyperkinetic disorder. Lancet 1998, 351:429-433.
• [3]Barkley RA, Fischer M, Smallish L, Fletcher K: Young adult follow-up of hyperactive children: antisocial activities and drug use. J Child Psychol Psychiatry 2004, 45:195-211.
• [4]ADDISS A Report Based On Research amongst Children and Parents Illustrating the Impact of ADHD on the School Day: Perspectives on ADHD; [http://www.addiss.co.uk/schoolreport.pdf webcite]
• [5]Office of the Deputy Prime Minister: Mental Health and Social Exclusion. Social Exclusion Unit Report; [http://www.socialfirmsuk.co.uk/system/files/mental_health_and_social_exclusion_main_report.pdf webcite]
• [6]Washbrook E, Propper C, Sayal K: Pre-school hyperactivity/attention problems and educational outcomes in adolescence: prospective longitudinal study. Br J Psychiatry 2013, 203:265-271.
• [7]Taylor E, Döpfner M, Sergeant J, Asherson P, Banaschewski T, Buitelaar J, Coghill D, Danckaerts M, Rothenberger A, Sonuga-Barke E, Steinhausen HC, Zuddas A: European clinical guidelines for hyperkinetic disorder - first upgrade. Eur Child Adolesc Psychiatry 2004, 13:7-30.
• [8]Banaschewski T, Coghill D, Santosh P, Zuddas A, Asherson P, Buitelaar J, Danckaerts M, Döpfner M, Faraone SV, Rothenberger A, Sergeant J, Steinhausen HC, Sonuga-Barke EJ, Taylor E: Long-acting medications for the hyperkinetic disorders - a systematic review and European treatment guideline. Eur Child Adolesc Psychiatry 2006, 15:476-495.
• [9]MTA Cooperative Group: A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 1999, 56:1073-1086.
• [10]Pliszka SR: The neuropsychopharmacology of attention-deficit/hyperactivity disorder. Biol Psychiatry 2005, 57:1385-1390.
• [11]Swanson JM, Elliott GR, Greenhill LL, Wigal T, Arnold LE, Vitiello B, Hechtman L, Epstein JN, Pelham WE, Abikoff HB, Newcorn JH, Molina BS, Hinshaw SP, Wells KC, Hoza B, Jensen PS, Gibbons RD, Hur K, Stehli A, Davies M, March JS, Conners CK, Caron M, Volkow ND: Effects of stimulant medication on growth rates across 3 years in the MTA follow-up. J Am Acad Child Adolesc Psychiatry 2007, 46:1015-1027.
• [12]Cox ER, Halloran DR, Homan SM, Welliver S, Mager DE: Trends in the prevalence of chronic medication use in children: 2002-2005. Pediatrics 2008, 122:E1053-E1061.
• [13]Graham J, Coghill D: Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder - epidemiology, prevention and management. CNS Drugs 2008, 22:213-237.
• [14]Karabekiroglu K, Yazgan YM, Dedeoglu C: Can we predict short-term side effects of methylphenidate immediate-release? Int J Psychiatry Clin Pract 2008, 12:48-54.
• [15]Berger I, Dor T, Nevo Y, Goldzweig G: Attitudes toward attention-deficit hyperactivity disorder (ADHD) treatment: parents’ and children’s perspectives. J Child Neurol 2008, 23:1036-1042.
• [16]Hupp SDA, Reitman D, Northup J, O’Callaghan P, LeBlanc M: The effects of delayed rewards, tokens, and stimulant medication on sportsmanlike behavior with ADHD-diagnosed children. Behav Modif 2002, 26:148-162.
• [17]Antshel KM, Barkley R: Psychosocial interventions in attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 2008, 17:421-437.
• [18]Sonuga-Barke EJS, Halperin JM: Developmental phenotypes and causal pathways in attention deficit/hyperactivity disorder: potential targets for early intervention? J Child Psychol Psychiatry 2010, 51:368-389.
• [19]Egger HL, Kondo D, Angold A: The epidemiology and diagnostic issues in preschool attention-deficit/hyperactivity disorder - a review. Infants Young Child 2006, 19:109-122.
• [20]Healey DM, Miller CJ, Castelli KL, Marks DJ, Halperin JM: The impact of impairment criteria on rates of ADHD diagnoses in preschoolers. J Abnorm Child Psychol 2008, 36:771-778.
• [21]Posner K, Melvin GA, Murray DW, Gugga SS, Fisher P, Skrobala A, Cunningham C, Vitiello B, Abikoff HB, Ghuman JK, Kollins S, Wigal SB, Wigal T, McCracken JT, McGough JJ, Kastelic E, Boorady R, Davies M, Chuang SZ, Swanson JM, Riddle MA, Greenhill LL: Clinical presentation of attention-deficit/hyperactivity disorder in preschool children: the preschoolers with attention-deficit/hyperactivity treatment study (PATS). J Child Adolesc Psychopharmacol 2007, 17:547-562.
• [22]King S, Griffin S, Hodges Z, Weatherly H, Asseburg C, Richardson G, Golder S, Taylor E, Drummond M, Riemsma R: A systematic review and economic model of the effectiveness and cost-effectiveness of methylphenidate, dexamfetamine and atomoxetine for the treatment of attention deficit hyperactivity disorder in children and adolescents. Health Technol Assess 2006, 10(23):iii–iv-xiii–146.
• [23]Eyberg SM, Boggs SR, Algina J: Parent–child interaction therapy - a psychosocial model for the treatment of young children with conduct problem behavior and their families. Psychopharmacol Bull 1995, 31:83-91.
• [24]Webster-Stratton C, Reid MJ, Hammond M: Preventing conduct problems, promoting social competence: a parent and teacher training partnership in head start. J Clin Child Psychol 2001, 30:283-302.
• [25]Bor W, Sanders MR, Markie-Dadds C: The effects of the Triple P positive parenting program on preschool children with co-occurring disruptive behavior and attentional/hyperactive difficulties. J Abnorm Child Psychol 2002, 30:571-587.
• [26]Thompson MJ, Laver-Bradbury C, Ayres M, Le Poidevin E, Mead S, Dodds C, Psychogiou L, Bitsakou P, Daley D, Weeks A, Brotman LM, Abikoff H, Thompson P, Sonuga-Barke EJ: A small-scale randomized controlled trial of the revised New Forest Parenting Programme for preschoolers with attention deficit hyperactivity disorder. Eur Child Adolesc Psychiatry 2009, 18:605-616.
• [27]Sonuga-Barke EJS, Daley D, Thompson M, Laver-Bradbury C, Weeks A: Parent-based therapies for preschool attention-deficit/hyperactivity disorder: a randomized, controlled trial with a community sample. J Am Acad Child Adolesc Psychiatry 2001, 40:402-408.
• [28]Sonuga-Barke EJ, Thompson M, Daley D, Laver-Bradbury C: Parent training for attention deficit/hyperactivity disorder: is it as effective when delivered as routine rather than as specialist care? Br J Clin Psychol 2004, 43:449-457.
• [29]Webster-Stratton C: The Incredible Years Parents, Teachers, and Children Training Series: Program Content, Methods, Research And Dissemination. Seattle, WA: Incredible Years, Inc.; 2011.
• [30]Barkley RA, Shelton TL, Crosswait C, Moorehouse M, Fletcher K, Barrett S, Jenkins L, Metevia L: Multi-method psycho-educational intervention for preschool children with disruptive behavior: preliminary results at post-treatment. J Child Psychol Psychiatry 2000, 41:319-332.
• [31]Pisterman S, Firestone P, McGrath P, Goodman JT, Webster I, Mallory R, Goffin B: The role of parent training in treatment of preschoolers with ADHD. Am J Orthopsychiatry 1992, 62:397-408.
• [32]Pisterman S, McGrath P, Firestone P, Goodman JT, Webster I, Mallory R: Outcome of parent-mediated treatment of preschoolers with attention deficit disorder with hyperactivity. J Consult Clin Psychol 1989, 57:628-635.
• [33]Webster-Stratton CH, Reid MJ, Beauchaine T: Combining parent and child training for young children with ADHD. J Clin Child Adolesc Psychol 2011, 40:191-203.
• [34]Webster-Stratton C, Reid MJ: Tailoring the Incredible Years parent, teacher, and child interventions for young children with ADHD. In ADHD in Preschool Children: Assessment and Treatment. Oxford: Oxford University Press: Ghuman JK, Ghuman HS; 2014:113-131.
• [35]Jones K, Daley D, Hutchings J, Bywater T, Eames C: Efficacy of the Incredible Years programme as an early intervention for children with conduct problems and ADHD: long-term follow-up. Child Care Health Dev 2008, 34:380-390.
• [36]Azevedo A, Seabra-Santos M, Gaspar M, Homem T: The Incredible Years basic parent training for Portuguese preschoolers with AD/HD behaviors: does it make a difference? Child Youth Care Forum 2013, 42:403-424.
• [37]Azevedo A, Seabra-Santos M, Gaspar M, Homem T: A parent-based intervention programme involving preschoolers with AD/HD behaviours: are children’s and mothers’ effects sustained over time? Eur Child Adolesc Psychiatry. 2013. doi:10.1007/s00787-013-0470-2
• [38]National Institute for Health and Clinical Excellence (NICE): Parent-Training/Education Programmes in the Management of Children with Conduct Disorders. NICE Technology Appraisal Guidance; 102. [http://www.nice.org.uk/nicemedia/pdf/ta102guidance.pdf webcite]
• [39]Edwards RT, Ceilleachair A, Bywater T, Hughes DA, Hutchings J: Parenting programme for parents of children at risk of developing conduct disorder: cost effectiveness analysis. Br Med J 2007, 334:682-685.
• [40]Sayal K, Goodman R, Ford T: Barriers to the identification of children with attention deficit/hyperactivity disorder. J Child Psychol Psychiatry 2006, 47:744-750.
• [41]Sayal K, Taylor E, Beecham J, Byrne P: Pathways to care in children at risk of attention-deficit hyperactivity disorder. Br J Psychiatry 2002, 181:43-48.
• [42]Chronis AM, Lahey BB, Pelham WE Jr, Williams SH, Baumann BL, Kipp H, Jones HA, Rathouz PJ: Maternal depression and early positive parenting predict future conduct problems in young children with attention-deficit/hyperactivity disorder. Dev Psychol 2007, 43:70-82.
• [43]Gardner F, Hutchings J, Bywater T, Whitaker C: Who benefits and how does it work? Moderators and mediators of outcome in an effectiveness trial of a parenting intervention. J Clin Child Adolesc Psychol 2010, 39:568-580.
• [44]Koerting J, Smith E, Knowles MM, Latter S, Elsey H, McCann DC, Thompson M, Sonuga-Barke EJ: Barriers to, and facilitators of, parenting programmes for childhood behaviour problems: a qualitative synthesis of studies of parents’ and professionals’ perceptions. Eur Child Adolesc Psychiatry 2013, 22(11):653-670.
• [45]Routh D: Hyperactivity. In Psychological Management of Pediatric Problems. 2nd edition. Edited by Magrab P. Baltimore: University Park Press; 1978.
• [46]Costello EJ, Edelbrock CS, Costello AJ: Validity of the NIMH diagnostic interview schedule for children - a comparison between psychiatric and pediatric referrals. J Abnorm Child Psychol 1985, 13:579-595.
• [47]Jeffree DM: McConkey R: Parent Involvement Project (PIP) Developmental Charts. 2nd edition. London: Hodder Education; 1998.
• [48]Sonuga-Barke EJS, Thompson M, Abikoff H: Miller Brotman L, Klein R: Non-pharmacological interventions for preschool ADHD: the case for specialized parent training. Infants Young Child 2006, 19:142-153.
• [49]Smith E, Koerting J, Latter S, Knowles MM, McCann DC, Thompson M, Sonuga-Barke EJ: Overcoming barriers to effective early parenting interventions for attention-deficit hyperactivity disorder (ADHD): parent and practitioner views. Child Care Health Devdoi:10.111/cch.12146
• [50]Webster-Stratton C: Preventing conduct problems in head start children: strengthening parenting competencies. J Consult Clin Psychol 1998, 66:715-730.
• [51]Scott S, Spender Q, Doolan M, Jacobs B, Aspland H: Multicentre controlled trial of parenting groups for childhood antisocial behaviour in clinical practice. Br Med J 2001, 323:194-197.
• [52]Center for the Study and Prevention of Violence: University of Colorado. Blueprints for Healthy Youth Development: We Know What Works; [http://www.colorado.edu/cspv/blueprints/ webcite]
• [53]Eames C, Daley D, Hutchings J, Hughes JC, Jones K, Martin P, Bywater T: The Leader Observation Tool: a process skills treatment fidelity measure for the Incredible Years parenting programme. Child Care Health Dev 2008, 34:391-400.
• [54]Tracey TJ, Kokotovic AM: Factor structure of the Working Alliance Inventory. Psychol Assess 1989, 1:207-210.
• [55]Riley AW, Lyman LM, Spiel G, Doepfner M, Lorenzo MJ, Ralston SJ, Grp AS: The Family Strain Index (FSI). Reliability, validity, and factor structure of a brief questionnaire for families of children with ADHD. Eur Child Adolesc Psychiatry 2006, 15:72-78.
• [56]Bussing R, Fernandez M, Harwood M, Hou W, Garvan CW, Eyberg SM, Swanson JM: Parent and teacher SNAP-IV ratings of attention deficit hyperactivity disorder symptoms - psychometric properties and normative ratings from a school district sample. Assessment 2008, 15:317-328.
• [57]Robinson EA, Eyberg SM, Ross AW: The standardization of an inventory of child conduct problem behaviors. J Clin Child Psychol 1980, 9:22-29.
• [58]Beecham J, Knapp M: Costing psychiatric interventions. In Measuring Mental Health Needs. 2nd edition. London: Gaskell: Thornicroft G; 2001:200-224.
• [59]Matza LS, Secnik K, Rentz AM, Mannix S, Sallee FR, Gilbert D, Revicki DA: Assessment of health state utilities for attention-deficit/hyperactivity disorder in children using parent proxy report. Qual Life Res 2005, 14:735-747.
• [60]Daley D, Sonuga-Barke EJS, Thompson M: Assessing expressed emotion in mothers of preschool AD/HD children: psychometric properties of a modified speech sample. Br J Clin Psychol 2003, 42:53-67.
• [61]Brotman LM, Gouley KK, Chesir-Teran D, Dennis T, Klein RG, Shrout P: Prevention for preschoolers at high risk for conduct problems: immediate outcomes on parenting practices and child social competence. J Clin Child Adolesc Psychol 2005, 34:724-734.
• [62]Brotman LM, Klein RG, Kamboukos D, Brown EJ, Coard SI, Sosinsky LS: Preventive intervention for urban, low-income preschoolers at familial risk for conduct problems: a randomized pilot study. J Clin Child Adolesc Psychol 2003, 32:246-257.
• [63]Golden M, Montare A, Bridger W: Verbal control of delay behavior in 2-year-old boys as a function of social-class. Child Dev 1977, 48:1107-1111.
• [64]Goldberg DP: General Health Questionnaire (GHQ-12). NFER-Nelson: Windsor; 1992.
• [65]Barkley RA, Murphy KR: Current symptom checklist. In Attention Hyperactivity Disorder: A Clinical Workbook. 2nd edition. Edited by Barkley RA, Murphy KR. New York: Guildford Press; 1998.
• [66]Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P, Grp C: Extending the CONSORT statement to randomized trials of nonpharmacologic treatment: explanation and elaboration. Ann Intern Med 2008, 148:295-309.
• [67]Trans European Network for Clinical Trials Services: TENALEA. [http://www.tenalea.com webcite]
• [68]Thompson MJ, Stevenson J, Sonuga-Barke E, Nott P, Bhatti Z, Price A, Hudswell M: The mental health of preschool children and their mothers in a mixed urban/rural population: I prevalence and ecological factors. Br J Psychiatry 1996, 168:16-20.
• [69]Barkley RA: Attention deficit disorder with hyperactivity. In Behavioral Assessment of Childhood Disorders. New York: Guilford: Mash EJ and Terdal LJ; 1988:69-104.
• [70]Mash EJ, Johnson C: Parental perceptions of child behavior problems, parenting self-esteem, and mothers’ reported stress in younger and older hyperactive and normal children. J Consult Clin Psychol 1983, 51:86-99.
• [71]Sonuga-Barke E, Stevenson J, Thompson M, Viney D: The structure of British pre-school and children’s behaviour problems. Psychol Med 1997, 27:909-918.
• [72]Swanson JM, Kraemer HC, Hinshaw SP, Arnold LE, Conners CK, Abikoff HB, Clevenger W, Davies M, Elliott GR, Greenhill LL, Hechtman L, Hoza B, Jensen PS, March JS, Newcorn JH, Owens EB, Pelham WE, Schiller E, Severe JB, Simpson S, Vitiello B, Wells K, Wigal T, Wu M: Clinical relevance of the primary findings of the MTA: success rates based on severity of symptoms of ADHD and ODD symptoms at the end of treatment. J Am Acad Child Adolesc Psychiatry 2001, 40:168-179.
• [73]Eyberg SM, Ross AW: Assessment of child behavior problems: the validation of a new inventory. J Clin Child Psychol 1978, 7:113-116.
• [74]Matza LS, Secnik K, Mannix S, Sallee FR: Parent-proxy EQ-5D ratings of children with attention-deficit hyperactivity disorder in the US and the UK. Pharmacoecon 2005, 23:777-790.
• [75]Campbell SB, Pierce EW, March CL, Ewing LJ, Szumowski EK: Hard-to-manage preschool boys: symptomatic behavior across contexts and time. Child Dev 1994, 65(3):836-851.
• [76]Buss AR, Plomin R: Temperament: Early Developing Personality Traits. Hillsdale NJ: Lawrence Erlbaum; 2008.
• [77]Brown H, Prescott R: Applied Mixed Models in Medicine. 2nd edition. Chichester: Wiley; 2006.
• [78]Yang XW, Shoptaw S: Assessing missing data assumptions in longitudinal studies: an example using a smoking cessation trial. Drug Alcohol Depend 2005, 77:213-225.
• [79]Valeri L, VanderWeele TJ: Mediation analysis allowing for exposure-mediator interactions and causal interpretation: theoretical assumptions and implementation with SAS and SPSS macros. Psychol Methods 2013, 18(2):137-150.
• [80]Drummond MF: Methods For The Economic Evaluation Of Health Care Programmes. 3rd edition. Oxford: Oxford University Press; 2005.
• [81]Thorn JC, Coast J, Cohen D, Hollingworth W, Knapp M, Noble SM, Ridyard C, Wordsworth S, Hughes D: Resource-use measurement based on patient recall: issues and challenges for economic evaluation. Appl Health Econ Health Policy 2013, 11:155-161.
• [82]Lloyd A, Hodgkins P, Sasane R, Akehurst R, Sonuga-Barke EJS, Fitzgerald P, Nixon A, Erder H, Brazier J: Estimation of utilities in attention-deficit hyperactivity disorder for economic evaluations. Patient 2011, 4:247-257.